Document Detail

The role of zinc protoporphyrin measurement in the differentiation between primary myelofibrosis and essential thrombocythaemia.
MedLine Citation:
PMID:  20922526     Owner:  NLM     Status:  In-Data-Review    
The differentiation between primary myelofibrosis (PMF) and essential thrombocythaemia (ET) may be difficult especially in early-stage disease. In PMF, increased levels of inflammatory cytokines induce impaired iron utilisation and disturbed erythropoiesis. In conditions with impaired iron support to erythropoiesis, zinc protoporphyrin (ZPP) is produced instead of heme. Here, we investigate whether ZPP concentration can be useful in the differentiation between PMF and ET. Seventy newly diagnosed patients (PMF, n = 24; ET, n = 46) were analysed. Intraerythrocytic ZPP concentration (normal ≤ 40 μmol/mol heme) was measured by an Aviv front-face haematofluorometer. In PMF, ZPP concentrations were significantly increased when compared to ET (99 ± 37 μmol/mol heme vs. 36 ± 13 μmol/mol heme, p < 0.0001). There was also a significant difference between early-stage PMF and advanced disease (77 ± 30 μmol/mol heme vs. 122 ± 31 μmol/mol heme, p = 0.003). ZPP >76 μmol/mol heme as observed in 71% of PMF patients were not seen in ET. In PMF patients responding to immunosuppressive treatment (n = 4), the increase in haemoglobin was accompanied by declining ZPP. In summary, by detecting the disturbed iron metabolism common in PMF, ZPP may assist in the differentiation between PMF and ET. Concentrations >60 μmol/mol heme are unlikely in ET if iron deficiency is excluded. ZPP determination is also useful for monitoring the effect of therapy in PMF.
Georgia Metzgeroth; Eva-Maria Kanders; Philipp Erben; Wolf-Karsten Hofmann; Jan Hastka
Related Documents :
3734266 - Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overl...
12187026 - Evaluation of tumor necrosis factor-alpha and erythropoietin serum levels in b-cell chr...
15957506 - Serum ferritin, transferrin and soluble transferrin receptor levels in multiple scleros...
12243556 - Increased erythropoietin levels in reactive thrombocytosis.
16215006 - Energy expenditure assessment and validation after acute spinal cord injury.
9447296 - Clinical and biochemical presentation of primary hyperparathyroidism in kansai district...
Publication Detail:
Type:  Journal Article     Date:  2010-10-05
Journal Detail:
Title:  Annals of hematology     Volume:  90     ISSN:  1432-0584     ISO Abbreviation:  Ann. Hematol.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107334     Medline TA:  Ann Hematol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  389-94     Citation Subset:  IM    
III Department of Medicine, University Medical Centre Mannheim, University of Heidelberg, Theodor-Kutzer Ufer 1-3, Mannheim, 68163, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminar...
Next Document:  Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.